The landscape of dementia diagnosis has evolved dramatically with the arrival of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology years just before indications emerge. Although these technological advancements stand for outstanding progress in knowledge neurodegenerative diseases,